Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43487,1774,1.00 [0.94-1.06],0.9560748380304026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,42781,424,0.95 [0.84-1.06],0.3584291115836807
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47517,322,0.92 [0.81-1.05],0.2210374207305786
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,32867,1547,1.01 [0.95-1.07],0.7652793753202767
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47409,214,0.89 [0.76-1.04],0.1445508978391218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44329,171,0.93 [0.77-1.11],0.4045342030242485
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",49855,212,0.90 [0.77-1.06],0.2057214579153655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49861,143,0.88 [0.72-1.07],0.196038466093177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43310,116,1.08 [0.88-1.34],0.4475392777722836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48232,231,0.92 [0.79-1.07],0.2835543543179331
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48153,152,0.89 [0.73-1.08],0.2287995806770769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50020,131,1.11 [0.91-1.35],0.2992908052130737
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50008,161,1.04 [0.87-1.24],0.6773757525524342
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",49996,149,1.06 [0.88-1.27],0.5365037799468728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,49335,103,0.93 [0.74-1.17],0.5553231049814744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47626,815,1.03 [0.95-1.12],0.4872702566532353
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47091,280,1.01 [0.88-1.16],0.8806547280691941
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47369,558,1.04 [0.94-1.14],0.4557766152434755
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40119,130,0.95 [0.77-1.17],0.6385611744799151
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40101,112,0.92 [0.74-1.15],0.4673874244358388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40501,512,1.00 [0.90-1.11],0.9978171756197174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40518,529,1.00 [0.90-1.11],0.995752389843739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22698,655,1.00 [0.91-1.09],0.994742316104302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18178,232,0.96 [0.82-1.12],0.6170329599241597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40092,103,0.93 [0.74-1.17],0.5476771933760034
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44673,1549,1.03 [0.97-1.10],0.2829596696395129
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47510,654,1.02 [0.93-1.12],0.6568192562636901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49115,229,0.96 [0.83-1.13],0.6461984428775711
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50173,219,0.94 [0.80-1.10],0.4250058451123892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,49630,129,1.16 [0.95-1.41],0.136720024582663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50186,130,1.04 [0.85-1.27],0.7093508628293901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Stomach,50278,98,0.94 [0.74-1.19],0.6114923755388278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,49738,579,1.01 [0.92-1.11],0.8216209815511979
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50190,212,0.96 [0.82-1.12],0.5907717876607683
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50198,178,0.95 [0.80-1.13],0.5334821457182071
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50082,101,0.95 [0.75-1.19],0.6345102390483806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",50086,100,0.97 [0.77-1.22],0.7630100165516468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,49919,384,1.08 [0.96-1.21],0.2018769132473709
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50215,170,1.17 [0.99-1.39],0.0669310875458362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,50019,361,0.95 [0.84-1.07],0.3680468858349092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of breast,27059,138,0.91 [0.75-1.11],0.3603105523180915
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,26565,980,1.02 [0.95-1.10],0.5889682712823885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47724,383,1.13 [1.01-1.27],0.0310685379075371
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47100,695,1.04 [0.96-1.14],0.3293374330542282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47100,695,1.04 [0.96-1.14],0.3293374330542282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43385,902,1.05 [0.98-1.14],0.1826595049103195
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49222,136,0.78 [0.64-0.96],0.0200774959810083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49684,166,1.00 [0.84-1.19],0.989189431989685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40598,2314,1.01 [0.96-1.06],0.7752009984000834
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47283,1061,1.03 [0.96-1.10],0.4693358346869057
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45765,270,0.98 [0.85-1.13],0.7466698747620895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,47968,217,0.95 [0.81-1.11],0.4982260062255818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45737,242,0.96 [0.83-1.12],0.6312183454343532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46578,1083,1.01 [0.94-1.08],0.8431671448089046
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46544,1049,1.01 [0.93-1.09],0.8405518785826778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46516,361,0.88 [0.77-1.01],0.0743424665615742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46521,359,0.88 [0.77-1.01],0.0769502495291403
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40255,1971,1.00 [0.94-1.05],0.8810143155686216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38547,263,0.96 [0.83-1.12],0.6156775007776606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40100,1816,1.00 [0.95-1.06],0.9308614013246914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38382,98,1.21 [0.97-1.52],0.0871815121020885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38453,169,0.96 [0.81-1.15],0.6935664101627698
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,42501,1281,1.02 [0.96-1.09],0.5234025160220845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41668,448,1.06 [0.95-1.19],0.2995628585092124
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49489,333,1.05 [0.92-1.18],0.4808901943421348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49615,241,1.14 [0.99-1.31],0.0754844811626249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,46796,114,0.90 [0.72-1.12],0.3488551642597082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50087,114,0.89 [0.72-1.11],0.304420363836552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41334,114,0.90 [0.72-1.12],0.3496772664585402
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Alcohol dependence,46818,136,1.11 [0.91-1.35],0.3085365083456565
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,46706,115,1.16 [0.94-1.43],0.1649383518424844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41326,106,0.93 [0.74-1.17],0.5480834068533604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",41859,639,1.05 [0.96-1.15],0.3173280243372848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression,47148,559,1.05 [0.95-1.15],0.3540416948759169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression or dysthymia,41354,484,1.09 [0.99-1.21],0.0879283551379749
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41467,247,0.95 [0.82-1.10],0.5082371271667998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Other anxiety disorders,47420,129,0.84 [0.68-1.03],0.0954730778498269
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,42982,2888,1.02 [0.98-1.07],0.3829658005775856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39010,257,1.01 [0.87-1.16],0.904756330981466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49987,204,1.03 [0.88-1.21],0.7164756064223379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47655,947,1.00 [0.93-1.08],0.9740097203601514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,47002,294,0.91 [0.79-1.04],0.155202021742656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,46866,158,0.99 [0.83-1.19],0.9402223429086228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49683,144,0.98 [0.81-1.19],0.8661599949817749
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48643,155,1.00 [0.83-1.20],0.9894239055440598
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,47038,330,1.06 [0.93-1.20],0.360033713017087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,49151,251,1.03 [0.89-1.19],0.686089070219166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48003,1313,1.04 [0.97-1.11],0.2583876862499284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",46926,236,1.05 [0.90-1.21],0.5549405239692324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47447,757,1.01 [0.93-1.10],0.8156212506178786
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49684,161,0.98 [0.82-1.18],0.8545207135035704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,49634,111,1.03 [0.83-1.28],0.8050999322356087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,49303,233,0.90 [0.77-1.05],0.1675760441809439
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",48973,721,0.98 [0.90-1.07],0.6822501968421212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48669,417,1.00 [0.89-1.12],0.997069714640246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48399,147,0.86 [0.70-1.04],0.1211077675123354
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48486,234,1.00 [0.86-1.16],0.969812914175517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48404,152,1.18 [0.99-1.42],0.0647606483224136
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43287,315,1.12 [0.99-1.28],0.0785995746382495
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43752,780,1.02 [0.94-1.11],0.6006609643238305
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48286,425,1.15 [1.04-1.29],0.0098223705921506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49613,105,1.30 [1.05-1.61],0.0151197801666508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4260,105,1.26 [1.02-1.57],0.0361196349784442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45458,105,1.30 [1.05-1.61],0.0145091158137509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,48939,183,0.90 [0.76-1.08],0.2614965837975133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,48857,101,0.92 [0.73-1.16],0.4907744303867211
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",48914,170,0.96 [0.80-1.14],0.6176014938411096
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49194,193,0.89 [0.75-1.05],0.1670235530205903
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50068,261,1.16 [1.01-1.33],0.0366057160509395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48570,204,1.01 [0.86-1.18],0.9299901578932028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35612,6434,0.97 [0.94-1.01],0.1279721079987733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49023,134,0.76 [0.62-0.94],0.0121062379728506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37469,4445,1.01 [0.97-1.05],0.6782589060101916
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,37535,4511,1.01 [0.97-1.05],0.6597275217271619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33180,156,0.85 [0.70-1.03],0.1053018907057172
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",45959,2358,0.92 [0.87-0.97],0.00154780738385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,45017,1416,0.92 [0.86-0.98],0.0095269916940357
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48211,473,1.00 [0.90-1.11],0.9834481681132968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48675,937,0.96 [0.89-1.04],0.3290114000709792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50015,184,0.94 [0.79-1.11],0.4508777303197783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44180,579,0.91 [0.82-1.01],0.0670593009615045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45442,1874,0.93 [0.88-0.98],0.0104822821378988
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48649,214,1.07 [0.92-1.25],0.3776656898172428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,48854,452,1.02 [0.92-1.14],0.7073338901594568
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48612,177,0.88 [0.73-1.05],0.1511801304489456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48614,179,0.88 [0.74-1.06],0.1746961127761549
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33195,171,0.90 [0.75-1.07],0.233492512331783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41678,117,1.02 [0.82-1.27],0.8520237928995354
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,41805,244,0.92 [0.79-1.07],0.2977566965576749
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27725,230,0.88 [0.75-1.03],0.1210446852927854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28356,861,0.83 [0.76-0.91],3.624472112357006e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,41694,133,0.92 [0.75-1.13],0.4222842551431123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41741,180,0.70 [0.58-0.85],0.0002169405600042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48174,407,0.96 [0.86-1.08],0.5217462020771455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48491,308,1.01 [0.88-1.15],0.9089125074144302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48557,259,1.04 [0.91-1.20],0.5495817072988158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48716,228,1.07 [0.92-1.24],0.3855974693204127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,47962,153,0.91 [0.76-1.10],0.350571619014502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48060,251,0.96 [0.83-1.11],0.5980171539207644
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47377,279,1.02 [0.89-1.17],0.7888810290923559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47336,238,1.03 [0.89-1.19],0.7174195851096752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",49834,228,1.04 [0.90-1.21],0.5899106018697824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,48029,931,0.91 [0.84-0.99],0.0201951680506206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,47899,173,0.94 [0.79-1.12],0.5046914319438156
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40088,4012,1.04 [1.00-1.08],0.0449606881439907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,49900,211,1.05 [0.90-1.23],0.5114991038238068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46597,440,1.00 [0.89-1.11],0.9450139211793604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46542,385,1.00 [0.89-1.13],0.9461923162597468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48445,492,0.95 [0.86-1.06],0.3749839676777848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48434,481,0.95 [0.85-1.05],0.3154116300196163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48688,1197,1.03 [0.96-1.10],0.3984354657041311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,47675,184,1.03 [0.87-1.22],0.724591910076595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,47738,247,1.10 [0.95-1.27],0.2050141178947951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48256,765,1.03 [0.95-1.12],0.4761094366045968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,47845,354,1.06 [0.94-1.20],0.3469008321152113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23112,125,0.97 [0.79-1.20],0.7845621939325653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,44922,1959,1.07 [1.02-1.13],0.0075278005146802
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,47949,342,1.08 [0.96-1.22],0.2080917829156512
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",47999,392,1.09 [0.97-1.23],0.131828192711487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",47999,392,1.09 [0.97-1.23],0.131828192711487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",46903,1620,1.07 [1.01-1.13],0.0294440320864577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Asthma,35884,1620,1.08 [1.02-1.14],0.0131073637008729
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35362,1620,1.07 [1.01-1.14],0.0167627524294143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",35860,1596,1.07 [1.01-1.14],0.0184962718926699
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49544,176,0.92 [0.77-1.10],0.3707706231494092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,47390,135,0.95 [0.78-1.16],0.6182733646518277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49698,135,0.95 [0.78-1.16],0.6207261740876759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47376,121,0.88 [0.71-1.09],0.2546720752412978
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,46213,217,0.96 [0.82-1.12],0.5974563515625761
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,46460,464,1.01 [0.91-1.12],0.8728810169562629
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,47792,211,1.10 [0.94-1.28],0.224910779579924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34193,11370,1.00 [0.98-1.03],0.8780107499947161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49249,814,1.01 [0.93-1.09],0.875619489792965
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50206,181,1.06 [0.90-1.25],0.4901200144852595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,50214,168,1.08 [0.91-1.29],0.3683781239398374
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,48645,210,1.01 [0.87-1.19],0.8702637875885333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48630,195,1.03 [0.87-1.21],0.7559566968710016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50189,200,1.08 [0.92-1.27],0.3360442454144799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48622,187,1.01 [0.85-1.19],0.9434518392299694
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48104,154,1.08 [0.90-1.30],0.3977877892898004
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50047,103,1.03 [0.82-1.29],0.8015992341217656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38229,535,0.99 [0.90-1.09],0.8434428919484859
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",41926,4232,0.99 [0.95-1.03],0.5066013300957901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,38357,663,1.08 [0.99-1.18],0.0867000404186869
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39050,1356,0.97 [0.91-1.03],0.3050118348086372
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,37844,150,1.02 [0.84-1.22],0.8676095061133149
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38093,399,1.01 [0.90-1.13],0.8679083156201179
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,37809,115,1.17 [0.95-1.44],0.137057617793163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,37995,301,0.92 [0.81-1.06],0.2423995957042741
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,37936,242,1.08 [0.93-1.25],0.3079309397373055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50000,168,1.07 [0.90-1.28],0.4221503565716611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,37938,244,0.93 [0.80-1.08],0.3403359821448675
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39288,1594,0.99 [0.93-1.05],0.6894619958709423
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,49955,246,0.96 [0.83-1.12],0.630559175116151
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,38553,859,0.96 [0.89-1.04],0.3288990551942595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38028,334,0.99 [0.87-1.12],0.8234210963677745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,49950,304,0.86 [0.75-0.99],0.0303670146700768
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,49909,200,0.96 [0.81-1.13],0.6130904937777193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,44010,3169,1.03 [0.98-1.07],0.2116180490118373
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,42000,1159,1.00 [0.93-1.07],0.995127443504087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,41088,247,0.97 [0.83-1.12],0.6716582809612268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,41043,202,1.08 [0.92-1.27],0.3312337613151385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42524,1683,1.05 [0.99-1.11],0.0937539197710917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48360,1485,1.05 [0.98-1.11],0.1465640464912676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,39318,3919,0.99 [0.95-1.03],0.647382949963117
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49599,113,1.10 [0.90-1.36],0.3551802987441678
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50130,157,1.09 [0.91-1.31],0.3278928696991582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,47032,157,1.10 [0.92-1.31],0.3130042769287847
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,46993,118,1.04 [0.85-1.28],0.690273712512351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50005,274,1.00 [0.87-1.15],0.9519884379417564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,47149,274,1.01 [0.88-1.16],0.931427122086983
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47121,246,1.01 [0.87-1.17],0.9087823690712532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48079,1204,1.05 [0.99-1.12],0.1256906799238082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48065,1190,1.05 [0.99-1.13],0.1267737825000276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35590,191,1.08 [0.92-1.27],0.3501475461318936
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal stricture,49358,191,1.09 [0.92-1.28],0.3199945264746074
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35525,126,1.07 [0.87-1.31],0.5104475816515979
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36578,1179,1.00 [0.93-1.07],0.965169553590668
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35723,324,0.96 [0.84-1.09],0.4890673155117173
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,35960,561,1.06 [0.96-1.16],0.2581283667219035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,47052,502,1.04 [0.94-1.15],0.4592085150229053
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49390,176,0.96 [0.81-1.15],0.6661016443619524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35678,279,0.86 [0.75-0.99],0.0388056395235242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35534,135,0.92 [0.75-1.12],0.4057833546948672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37130,1731,1.00 [0.95-1.06],0.9283887931420136
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,35929,530,1.00 [0.90-1.10],0.9439551182118796
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49362,148,0.95 [0.78-1.15],0.5857595162171825
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,48675,241,0.77 [0.66-0.91],0.001388078570187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,48570,136,0.77 [0.62-0.95],0.0141915375203269
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47605,1224,1.02 [0.96-1.09],0.5401815374905442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,47370,989,1.03 [0.95-1.11],0.4665594025152236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,46574,193,1.08 [0.92-1.27],0.3707991424530045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46481,100,1.00 [0.79-1.26],0.9884346757598592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,46509,128,1.04 [0.85-1.27],0.7359823421500524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),49933,128,1.03 [0.84-1.26],0.7716100213258306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47555,604,1.08 [0.98-1.18],0.1042342163326934
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47086,135,1.27 [1.06-1.53],0.0111544213686021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,47062,111,1.27 [1.04-1.56],0.0211787985229136
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47047,96,1.07 [0.85-1.35],0.574331531761183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47336,385,1.03 [0.92-1.16],0.5765113263482815
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,47322,371,1.02 [0.91-1.15],0.7232256356398648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44073,3049,0.96 [0.92-1.00],0.0712186419574561
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49372,203,1.02 [0.87-1.20],0.8204303289123254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49442,893,0.95 [0.88-1.02],0.1682208577559205
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47136,1137,0.99 [0.92-1.06],0.7584475306941955
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48481,774,0.95 [0.88-1.04],0.2719651395253268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",47882,175,0.89 [0.75-1.06],0.1928591280339221
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48202,495,0.98 [0.89-1.09],0.7758700896518198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49717,176,0.98 [0.83-1.17],0.8449762441059863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49678,137,1.03 [0.84-1.25],0.8030381698666829
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49644,103,1.01 [0.81-1.27],0.9200318252558112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49681,109,0.77 [0.61-0.98],0.0303164750779476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49676,104,0.77 [0.60-0.98],0.0318987622049285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48661,112,1.02 [0.82-1.27],0.8603102983806084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49260,711,0.93 [0.86-1.02],0.1276503609957855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46180,181,0.92 [0.77-1.09],0.3215465773808509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46197,198,0.83 [0.70-0.99],0.0331986347181979
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46150,151,0.85 [0.70-1.04],0.110826414840922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46431,432,1.07 [0.96-1.20],0.1968996916998219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46383,384,1.05 [0.94-1.18],0.3769144437454155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36190,7780,1.04 [1.01-1.07],0.0223637344884964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39343,4513,1.03 [0.99-1.07],0.1157912598392818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45296,2372,1.07 [1.02-1.12],0.0062231619578425
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35129,299,1.12 [0.98-1.28],0.084876808079976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35735,905,1.01 [0.93-1.09],0.8309785534828541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49434,287,1.13 [0.99-1.28],0.077751314426333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49454,259,1.16 [1.01-1.33],0.0321262710738132
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37076,2246,1.04 [0.99-1.10],0.1208639951616934
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42098,2246,1.04 [0.98-1.09],0.1662295389802408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,34963,133,1.00 [0.81-1.23],0.9987689981443186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49140,129,0.96 [0.77-1.18],0.6729740115111442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35259,429,0.93 [0.83-1.05],0.2256589745033752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,34969,139,0.99 [0.81-1.22],0.9570522004829104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35381,551,1.00 [0.90-1.11],0.9798954621284108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",49945,271,1.05 [0.91-1.21],0.4871238207360444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,35864,1034,1.05 [0.97-1.13],0.2302508661066864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35605,775,1.00 [0.92-1.10],0.9105722337913532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37336,2506,1.03 [0.98-1.08],0.2674474056866093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),34957,127,0.97 [0.79-1.19],0.7499094419930644
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35290,460,1.02 [0.91-1.13],0.7650798077783433
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34939,109,1.12 [0.90-1.39],0.3129362600745634
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),34947,117,1.10 [0.89-1.36],0.3919145804457514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35769,939,1.05 [0.97-1.13],0.2109199331959657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35640,810,1.06 [0.98-1.15],0.1551204396956078
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,38907,548,0.94 [0.85-1.04],0.2040928159961045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49186,251,0.92 [0.80-1.07],0.2935681019279739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49044,109,1.15 [0.93-1.42],0.1879982858810577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43442,126,1.00 [0.81-1.23],0.9756363414337256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,43889,573,0.91 [0.82-1.00],0.0568185407239016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45126,1810,0.96 [0.91-1.01],0.1265722191157628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43682,366,0.93 [0.82-1.05],0.2603553162850158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43482,166,0.88 [0.73-1.06],0.1715390730471752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44746,1430,0.97 [0.91-1.03],0.3489698658806272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43416,100,1.15 [0.92-1.43],0.2329208973545428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43771,455,1.00 [0.90-1.12],0.9577538539222016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43509,193,1.02 [0.87-1.21],0.7956367729241565
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43469,153,0.93 [0.77-1.12],0.4423915314831541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43590,274,0.94 [0.81-1.08],0.373394436773298
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43440,124,0.98 [0.80-1.21],0.8786828099416636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,43917,601,0.97 [0.88-1.07],0.5335798673221535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43540,616,1.09 [1.00-1.20],0.0570392867879871
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43058,134,1.05 [0.86-1.28],0.6206615792490864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43095,171,1.06 [0.89-1.26],0.5246456807749262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43127,203,1.18 [1.01-1.38],0.0336271815789845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43020,96,1.19 [0.95-1.49],0.1346290331004103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43148,224,1.13 [0.97-1.31],0.1245840422644848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43123,199,1.07 [0.91-1.26],0.4154233834866806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43441,517,1.04 [0.94-1.15],0.4155863471788222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43031,107,0.92 [0.73-1.16],0.4843802315258806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43079,155,1.04 [0.87-1.25],0.6527478549074495
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43171,247,1.11 [0.96-1.28],0.1496326839462576
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43044,120,0.84 [0.68-1.05],0.1272841828143487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",43799,875,1.03 [0.95-1.11],0.5035579061274378
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43258,334,1.01 [0.89-1.14],0.9066777241349556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43390,466,1.01 [0.91-1.12],0.8631877784231452
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46556,335,0.99 [0.87-1.12],0.8580282248618545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,46986,765,0.96 [0.88-1.04],0.3124531642211878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46317,96,0.97 [0.77-1.23],0.8307736794702971
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46337,116,0.88 [0.71-1.10],0.2593223158786036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46423,202,0.92 [0.78-1.08],0.3193871711639973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,39858,8333,0.97 [0.94-1.00],0.0398189485307687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19935,1257,1.01 [0.94-1.08],0.8175611930304825
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45122,499,1.01 [0.91-1.13],0.7948757393210506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44758,135,1.01 [0.83-1.24],0.9072633963749892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45317,107,1.10 [0.89-1.37],0.3750428452863561
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45347,137,0.98 [0.80-1.20],0.8265211860468509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45343,133,0.94 [0.77-1.16],0.5826438681314342
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49547,480,0.94 [0.84-1.05],0.2541997131145709
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49378,140,1.07 [0.88-1.30],0.4894725181119016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49415,348,0.99 [0.87-1.12],0.8242802757712864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49232,165,0.90 [0.75-1.08],0.2603842925805841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,45898,2038,0.98 [0.93-1.04],0.5135021242725956
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,44044,184,0.97 [0.82-1.15],0.6994431103914587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44021,161,1.06 [0.89-1.27],0.5044032140619135
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44394,534,0.99 [0.90-1.10],0.9159682857335766
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44082,222,0.94 [0.80-1.10],0.458220494906155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45184,1324,0.99 [0.92-1.05],0.6511314424337555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19231,553,1.04 [0.94-1.15],0.4434937609390108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18782,104,1.05 [0.84-1.32],0.6572246986825026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,18777,99,0.95 [0.75-1.20],0.643806013152987
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18842,164,1.06 [0.89-1.27],0.5197581333278742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18839,161,1.13 [0.94-1.35],0.183665123851366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18891,213,0.88 [0.75-1.04],0.1405876738481529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26800,473,0.92 [0.83-1.03],0.1351427396035246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26474,147,0.94 [0.77-1.13],0.4985505204890764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26495,168,0.98 [0.82-1.17],0.8511628192421051
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26438,111,0.82 [0.66-1.03],0.0863030102808437
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,0.94 [0.85-1.04],0.2366059640859502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26334,130,0.80 [0.64-0.98],0.0327249766416089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.01 [0.87-1.17],0.9023435567157596
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24702,4510,0.99 [0.95-1.02],0.440509313490258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,20551,359,1.14 [1.01-1.28],0.0332981929193341
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20288,96,1.36 [1.09-1.69],0.0062873204210757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20356,164,1.12 [0.94-1.33],0.2214527297629334
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,20970,778,1.02 [0.93-1.10],0.7120168433465023
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20600,408,0.96 [0.86-1.08],0.5242606059863759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21128,936,0.96 [0.89-1.04],0.2809737976441123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20502,310,0.90 [0.79-1.03],0.1312163768346531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20628,436,1.04 [0.93-1.16],0.5014718981980997
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20287,95,1.00 [0.79-1.26],0.9684669613303186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20376,184,1.00 [0.84-1.18],0.9977708024193188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27076,260,1.05 [0.91-1.21],0.4769954392737828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27086,246,1.05 [0.91-1.21],0.4974855505178488
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27111,137,1.12 [0.93-1.36],0.2299167510571741
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27102,151,1.12 [0.93-1.34],0.2267505450243279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,0.94 [0.77-1.14],0.5012466732638541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20305,113,0.99 [0.80-1.23],0.920826234357258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20332,140,1.01 [0.83-1.22],0.9585800483128506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,27007,463,1.10 [0.99-1.23],0.0621730213518945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21511,1319,1.04 [0.98-1.11],0.2042936353549453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21050,858,1.03 [0.95-1.12],0.4644443316912012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27092,194,1.01 [0.86-1.19],0.8763926315700998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20652,460,0.96 [0.86-1.07],0.4692275600184892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20519,327,0.96 [0.85-1.09],0.5538723823012547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21074,882,0.94 [0.86-1.01],0.1019603697800918
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female infertility,20307,115,0.99 [0.80-1.23],0.9254267337149494
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20300,108,0.97 [0.78-1.22],0.8050108853636092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,1.01 [0.93-1.10],0.8445122503417039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.98 [0.91-1.06],0.6020619978451198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27108,463,1.01 [0.91-1.13],0.8170171123158652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26776,131,1.08 [0.89-1.32],0.4394671008953277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26834,189,0.95 [0.80-1.12],0.5397261094447137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26800,155,0.98 [0.81-1.18],0.8456769920616464
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27127,165,0.97 [0.81-1.17],0.7750244391721475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27129,162,0.97 [0.81-1.17],0.7666699540924915
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27124,406,0.89 [0.79-1.01],0.0705212991360217
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26837,119,0.75 [0.60-0.94],0.01344480156742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,26945,227,0.88 [0.75-1.03],0.1101792153334659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26389,145,1.10 [0.91-1.33],0.321653806554234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26440,196,0.92 [0.78-1.10],0.3609990277148368
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26492,248,1.03 [0.88-1.19],0.7230226697544213
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26388,144,1.10 [0.91-1.34],0.3124038617059731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26379,135,1.09 [0.90-1.33],0.3728344234328959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.87 [0.72-1.06],0.1804118573244665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,1.01 [0.86-1.18],0.9086398671534508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.93 [0.82-1.04],0.2042258143830388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,1.00 [0.91-1.11],0.9570924399564256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,1.03 [0.86-1.23],0.7392121103049616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.98 [0.80-1.20],0.8408425864291587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26040,99,0.95 [0.75-1.20],0.6702046908795263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.92 [0.81-1.05],0.2230179213813068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27056,251,0.84 [0.72-0.98],0.02818925902531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27124,247,1.05 [0.91-1.22],0.4871723279274309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27115,238,1.04 [0.90-1.21],0.5988117709268039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49486,119,0.90 [0.72-1.12],0.3301029814025309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45266,1164,0.95 [0.88-1.01],0.1240867072363481
